ORIGINAL ARTICLE, innovatingcanada.ca, 2021

McMaster Innovation Park driving progress in life sciences to benefit Canadians’ health and strengthen the economy.

It has become clear that advanced manufacturing in the biotech industry will be critical to Canada’s recovery from COVID-19 & preparedness for another health crisis.

Without domestic capacity to produce COVID-19 vaccines, Canada has had to depend on other countries. “I think the nation learned an important lesson, that without domestic capacity, how do we look after our citizens during a crisis? That is one important aspect, but it also extends into economic growth,” says Ty Shattuck, CEO of McMaster Innovation Park (MIP) in Hamilton, Ont.

To continue reading this article CLICK HERE